美国肠易激综合征及其亚型的医疗保健费用
基于Optum去标识化Clinformatics Data Mart数据库2016—2021年数据,回顾性队列分析比较102,887例肠易激综合征(IBS)患者与102,887例对照,IBS患者年总费用中位数13,288美元高于对照5,999美元(P<0.001),IBS相关年费用中位数1,127美元,不同亚型费用存在差异。
要点
- IBS患者年总费用中位数13,288美元,高于对照的5,999美元(P<0.001)。
- IBS相关年费用中位数1,127美元。
- 便秘型IBS费用最高:总费用16,005美元,IBS相关费用2,222美元。
核心结论
- IBS患者较无IBS者医疗利用更高且全因费用显著更高,且护理费用因IBS亚型而异。
研究设计与样本
- 回顾性队列分析,使用Optum去标识化Clinformatics Data Mart数据库2016—2021年数据,纳入102,887例IBS患者(ICD-10识别)和102,887例随机对照,采用倾向评分加权比较费用,并用Elixhauser合并症指数衡量合并症。
主要发现
- IBS患者年总费用中位数(四分位距)为13,288(5,307-37,071)美元,高于对照的5,999(1,800-19,426)美元(P<0.001)。
- IBS患者IBS相关年费用中位数为1,127(370-5,544)美元。
- 倾向评分加权分析显示不同IBS亚型间总全因费用、IBS相关费用及单项服务费用存在差异。
- 便秘型IBS费用最高:全因费用中位数16,005(6,384-43,972)美元,IBS相关费用中位数2,222(511-7,887)美元。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Contemporaneous data on healthcare costs of irritable bowel syndrome (IBS) in the United States are lacking. We aimed to estimate all-cause and IBS-specific costs in patients with and without IBS and to compare costs across IBS subtypes. METHODS: Using Optum's deidentified Clinformatics Data Mart Database, we performed a retrospective cohort analysis of patients with and without IBS using data spanning 2016-2021. Patients with IBS were identified by ICD-10 codes. Controls were randomly selected from Clinformatics Data Mart Database participants. Primary outcomes were total all-cause and IBS-specific healthcare costs. Secondary outcomes were costs of individual services associated with any claim. Costs were compared between IBS and control groups and across IBS subtypes using propensity score weighting. Comorbidities were measured with the Elixhauser Comorbidity Index. RESULTS: Comparison of 102,887 patients with IBS (77.9% female; mean ± SD age 60.3 ± 18.4 years; 75.8% white) and 102,887 controls demonstrated higher median (interquartile range) total costs per year ( P < 0.001) for patients with IBS ($13,288 [5,307-37,071]) than controls ($5,999 [1,800-19,426]). IBS was associated with increased healthcare utilization and higher median annual costs per patient for all services. Median (interquartile range) annual IBS-specific spending was $1,127 (370-5,544) per patient. Propensity score-weighted analysis across IBS subtypes revealed differences in total all-cause and IBS-specific costs and in costs of individual services. Highest spending was observed in IBS with constipation (all-cause $16,005 [6,384-43,972]; IBS-specific $2,222 [511-7,887]). DISCUSSION: Individuals with IBS exhibit higher healthcare utilization and incur substantially higher all-cause costs than those without. Care costs differ by IBS subtype.
引用
- Shin A, Xu H. Healthcare Costs of Irritable Bowel Syndrome and Irritable Bowel Syndrome Subtypes in the United States. Am J Gastroenterol. 2024. PMID: 38483304. doi:10.14309/ajg.0000000000002753
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。